Cerebrospinal fluid levels of sAPPα and sAPPβ in Lewy body and Alzheimer's disease: Clinical and neurochemical correlates

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Mulugeta, Ezra ^a,b   Londos, Elisabet ^c   Hansson, Oskar ^c   Ballard, Clive ^b   Skogseth, Ragnhild ^a   Minthon, Lennart ^c   Blennow, Kaj ^d   Zetterberg, Henrik ^d   Aarsland, Dag ^a,e,f  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; AMYLOID PRECURSOR PROTEIN BETA; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROCHEMISTRY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 81555207173     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/495025     Document Type: Article

References (28)

1. Blennow K., Hampel H., Weiner M., Zetterberg H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nature Reviews Neurology 2010 6 3 131 144
2. Querfurth H. W., LaFerla F. M., Alzheimer's disease New England Journal of Medicine 2011 362 329 344
3. Mattson M. P., Pathways towards and away from Alzheimer's disease Nature 2004 430 7000 631 639 (Pubitemid 39061671)
4. Hiltunen M., van Groen T., Jolkkonen J., Functional roles of amyloid- protein precursor and amyloid- peptides: evidence from experimental studies Journal of Alzheimer's Disease 2009 18 2 401 412
5. Mattson M. P., Cellular actions of -amyloid precursor protein and its soluble and fibrillogenic derivatives Physiological Reviews 1997 77 4 1081 1132 (Pubitemid 27459580)
6. Zhang Y. W., Thompson R., Zhang H., Xu H., APP processing in Alzheimer's disease Molecular Brain 2011 4 3
7. Li H., Wang B., Wang Z., Guo Q., Tabuchi K., Hammer R. E., Sdhof T. C., Zheng H., Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP Proceedings of the National Academy of Sciences of the United States of America 2010 107 40 17362 17367
8. Lewczuk P., Kamrowski-Kruck H., Peters O., Heuser I., Jessen F., Popp J., Brger K., Hampel H., Frlich L., Wolf S., Prinz B., Jahn H., Luckhaus C., Perneczky R., Hll M., Schrder J., Kessler H., Pantel J., Gertz H. J., Klafki H. W., Klsch H., Reulbach U., Esselmann H., Maler J. M., Bibl M., Kornhuber J., Wiltfang J., Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study Molecular Psychiatry 2010 15 2 138 145
9. Gabelle A., Roche S., Gény C., Bennys K., Labauge P., Tholance Y., Quadrio I., Tiers L., Gor B., Chaulet C., Vighetto A., Croisile B., Krolak-Salmon P., Touchon J., Perret-Liaudet A., Lehmann S., Correlations between soluble / forms of amyloid precursor protein and A 38, 40, and 42 in human cerebrospinal fluid Brain Research 2010 1357 C 175 183
10. Zetterberg H., Andreasson U., Hansson O., Wu G., Sankaranarayanan S., Andersson M. E., Buchhave P., Londos E., Umek R. M., Minthon L., Simon A. J., Blennow K., Elevated cerebrospinal fluid BACE1 activity in incipient alzheimer disease Archives of Neurology 2008 65 8 1102 1107
11. Olsson A., Hglund K., Sjgren M., Andreasen N., Minthon L., Lannfelt L., Buerger K., Mller H. -J., Hampel H., Davidsson P., Blennow K., Measurement of -and -secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients Experimental Neurology 2003 183 1 74 80 (Pubitemid 37075858)
12. Kalaitzakis M. E., Walls A. J., Pearce R. K. B., Gentleman S. M., Striatal A peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes Neurobiology of Disease 2011 41 2 377 384
13. Mulugeta E., Londos E., Ballard C., Alves G., Zetterberg H., Blennow K., Skogseth R., Minthon L., Aarsland D., CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies Journal of Neurology, Neurosurgery and Psychiatry 2011 82 2 160 164
14. Aarsland D., Rongve A., Piepenstock Nore S., Skogseth R., Skulstad S., Ehrt U., Hoprekstad D., Ballard C., Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria Dementia and Geriatric Cognitive Disorders 2008 26 5 445 452
15. Lippa C. F., Duda J. E., Grossman M., Hurtig H. I., Aarsland D., Boeve B. F., Brooks D. J., Dickson D. W., Dubois B., Emre M., Fahn S., Farmer J. M., Galasko D., Galvin J. E., Goetz C. G., Growdon J. H., Gwinn-Hardy K. A., Hardy J., Heutink P., Iwatsubo T., Kosaka K., Lee V. M. Y., Leverenz J. B., Masliah E., McKeith I. G., Nussbaum R. L., Olanow C. W., Ravina B. M., Singleton A. B., Tanner C. M., Trojanowski J. Q., Wszolek Z. K., DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 2007 68 11 812 819 (Pubitemid 46568532)
16. Aarsland D., Ballard C., Walker Z., Bostrom F., Alves G., Kossakowski K., Leroi I., Pozo-Rodriguez F., Minthon L., Londos E., Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial The Lancet Neurology 2009 8 7 613 618
17. Aarsland D., Londos E., Ballard C., Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity International Psychogeriatrics 2009 21 2 216 219
18. McKeith I. G., Dickson D. W., Lowe J., Emre M., O'Brien J. T., Feldman H., Cummings J., Duda J. E., Lippa C., Perry E. K., Aarsland D., Arai H., Ballard C. G., Boeve B., Burn D. J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C. G., Gomez-Tortosa E., Halliday G., Hansen L. A., Hardy J., Iwatsubo T., Kalaria R. N., Kaufer D., Kenny R. A., Korczyn A., Kosaka K., Lee V. M. Y., Lees A., Litvan I., Londos E., Lopez O. L., Minoshima S., Mizuno Y., Molina J. A., Mukaetova-Ladinska E. B., Pasquier F., Perry R. H., Schulz J. B., Trojanowski J. Q., Yamada M., Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium Neurology 2005 65 12 1863 1872 (Pubitemid 43970103)
19. McKhann G., Drachman D., Folstein M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 1984 34 7 939 944 (Pubitemid 14076461)
20. Emre M., Dementia associated with Parkinson's disease Lancet Neurology 2003 2 4 229 237 (Pubitemid 37443310)
21. Jorm A. F., The informant questionnaire on cognitive decline in the elderly (IQCODE): a review International Psychogeriatrics 2004 16 3 275 293 (Pubitemid 39441493)
22. Bateman R. J., Wen G., Morris J. C., Holtzman D. M., Fluctuations of CSF amyloid- levels: implications for a diagnostic and therapeutic biomarker Neurology 2007 68 9 666 669 (Pubitemid 46667813)
23. Nitsch R. M., Slack B. E., Wurtman R. J., Growdon J. H., Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors Science 1992 258 5080 304 307
24. Nitsch R. M., Farber S. A., Growdon J. H., Wurtman R. J., Release of amyloid -protein precursor derivatives by electrical depolarization of rat hippocampal slices Proceedings of the National Academy of Sciences of the United States of America 1993 90 11 5191 5193 (Pubitemid 23183003)
25. Nitsch R. M., Deng A., Wurtman R. J., Growdon J. H., Metabotropic glutamate receptor subtype mGlur1 stimulates the secretion of the amyloid -protein precursor ectodomain Journal of Neurochemistry 1997 69 2 704 712 (Pubitemid 27327973)
26. Farber S. A., Nitsch R. M., Schulz J. G., Wurtman R. J., Regulated secretion of -amyloid precursor protein in rat brain Journal of Neuroscience 1995 15 11 7442 7451 (Pubitemid 3010080)
27. Turner P. R., O'Connor K., Tate W. P., Abraham W. C., Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory Progress in Neurobiology 2003 70 1 1 32 (Pubitemid 36966639)
28. Sydow A., Van Der Jeugd A., Zheng F., Ahmed T., Balschun D., Petrova O., Drexler D., Zhou L., Rune G., Mandelkow E., D'Hooge R., Alzheimer C., Mandelkow E.-M., Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant Journal of Neuroscience 2011 31 7 2511 2525